Stat Profile Prime Plus Analyzer System

FDA 510(k) K200204 · Nova Biomedical Corporation

Substantially Equivalent

510(k) numberK200204

Submission

Device name
Stat Profile Prime Plus Analyzer System
Applicant
Nova Biomedical Corporation
Walham, MA, US
Received
January 28, 2020
Decision date
April 6, 2020
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GGZ – Oxyhemoglobin
Device class
Class II (moderate risk)
Regulation
21 CFR 864.7500
Specialty
Hematology

Other 510(k)s with product code GGZ

510(k)DeviceApplicantDecision
K180186Stat Profile Prime Plus Analyzer SystemGGZ · Traditional Nova Biomedical Corporation08/23/2018SE

More from Nova Biomedical Corporation

510(k)DeviceDecision
K251281Nova Max Creat eGFR Monitoring SystemSHB · Traditional 01/21/2026SE
K252206Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX · Dual Track 01/09/2026SE
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerLCP · Dual Track 11/22/2024SE
K221813Nova Allegro UACR Assay, Nova Allegro AnalyzerCGX · Dual Track 11/19/2024SE
K232075StatStrip Glucose Hospital Meter SystemPZI · Dual Track 02/23/2024SE
K221900Stat Profile Prime Plus Analyzer SystemCHL · Traditional 09/29/2023SE
K203549Nova Primary Glucose Analyzer SystemCGA · Traditional 10/18/2022SE
K200403Stat Profile Prime Plus Analyzer SystemJGS · Traditional 04/14/2020SE
K200349Stat Profile Prime Plus Analyzer SystemCGA · Traditional 03/13/2020SE
K193246Stat Profile Prime Plus Analyzer SystemCHL · Traditional 01/24/2020SE

Questions and answers

When was Stat Profile Prime Plus Analyzer System cleared by the FDA?

Stat Profile Prime Plus Analyzer System (K200204) received a 510(k) decision of Substantially Equivalent on April 6, 2020, 69 days after the submission was received.

What is the product code of K200204?

The FDA product code is GGZ – Oxyhemoglobin, a Class II (moderate risk) device regulated under 21 CFR 864.7500.